SLC30A8 and type 2 diabetes mellitus: Common polymorphisms and rare heterozygous loss-of-function (LoF) mutations in SLC30A8 are associated with reduced risk of developing type 2 diabetes, a disease that is characterised primarily by impaired insulin secretion and sensitivity.